MUMPS IGM

The Mumps IgM test measures IgM antibodies to the mumps virus in a venous blood sample to identify recent or acute infection; this service includes trained phlebotomist home collection and laboratory analysis, available across Dubai and the UAE. It is commonly used to confirm clinical suspicion in patients with parotitis, fever or when contact tracing and outbreak control are needed in schools, workplaces and healthcare settings, enabling timely isolation and public‑health action. Note that IgM may not appear until several days after symptom onset and can be influenced by recent vaccination or prior immunity, so results should be interpreted by a clinician and repeat testing may be recommended when clinically indicated.

• Mumps IgM Antibody (IgM)
• Mumps IgM Index (AU/mL)
• Qualitative Result: Reactive / Non‑Reactive
• Sample Type: Serum / Plasma
• Method: ELISA

• Detects mumps-specific IgM antibodies to identify recent or acute mumps infection
• Home blood collection by trained phlebotomists across Dubai and the UAE
• Quick laboratory processing with results typically available within 24–48 hours
• Suitable for symptomatic individuals, recent-exposure assessment, and outbreak confirmation
• Samples processed in accredited diagnostic laboratories in line with UAE health standards

• Detects recent/acute mumps infection by measuring IgM antibodies
• Convenient home blood collection by trained phlebotomists across Dubai and the UAE
• Rapid laboratory turnaround — results typically available within 24–48 hours
• Performed in accredited labs with secure, downloadable report for your physician or employer
• Suitable for symptomatic testing, recent-exposure screening, and clinical follow-up

• At-home venous blood collection by a certified phlebotomist, available across Dubai and the UAE
• Mumps-specific IgM antibody detection to identify recent/acute infection—most reliable within 1–3 weeks of symptom onset or exposure
• Rapid laboratory processing with secure electronic results delivery (typical turnaround 24–48 hours)
• Suitable for symptomatic individuals and recent contacts; no fasting required; clinical follow-up recommended for confirmation